In vivo effects of DL-alpha-difluoromethylornithine on the polyamine and nucleotide phosphate metabolism in P388/S leukemia cells

Exp Cell Biol. 1986;54(1):8-15. doi: 10.1159/000163338.

Abstract

In vivo effects of DL-alpha-difluoromethylornithine (DFMO) on the metabolism of polyamines and nucleotide phosphates were monitored in P388/S leukemia cells grown intraperitoneally in BDF1 inbred male mice. Inhibiting the ornithine decarboxylase (ODC) activity DFMO depleted putrescine and spermidine to 30-50 and 50-60%, respectively, and increased spermine to 25-60% compared with the controls, when given as 2% solution in drinking water of the tumor-bearing animals. DFMO treatment caused a parallel 56% elevation of total nucleotide content in tumor cells with distinct and significant increase of some nucleotide phosphates. The most pronounced alterations were shown in the intracellular UTP (202%), CTP (103%), ADP (92%) and ATP (71%) concentrations. Changes in polyamine and nucleotide phosphate metabolisms were dependent on tumor progression. A possible explanation of the metabolic events induced by DFMO is discussed.

MeSH terms

  • Animals
  • Cell Line
  • Eflornithine
  • Leukemia P388 / metabolism*
  • Leukemia, Experimental / metabolism*
  • Male
  • Mice
  • Mice, Inbred Strains
  • Nucleotides / metabolism*
  • Ornithine / analogs & derivatives*
  • Ornithine / pharmacology
  • Ornithine Decarboxylase Inhibitors
  • Polyamines / metabolism*
  • Putrescine / metabolism
  • Spermidine / metabolism
  • Spermine / metabolism
  • Time Factors

Substances

  • Nucleotides
  • Ornithine Decarboxylase Inhibitors
  • Polyamines
  • Spermine
  • Ornithine
  • Spermidine
  • Putrescine
  • Eflornithine